DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
GW-328267
1
Small molecule
Investigational
Unknown
Unknown
Acute Lung Injury
Unknown
GW-328267
×
Maximum Phase:
1
First Approval:
None
UNII:
DJF621DE4F
Molecule Type:
Small molecule
Molecular Formula:
C21H26N10O4
Molecular Weight:
482.51
AlogP:
-0.58
PSA:
195.17
HBD:
5.0
HBA:
#RotB:
8.0
Source:
TAREXTUMAB
1
Antibody
Investigational
Unknown
Unknown
Neoplasms; Pancreatic Neoplasms; Small Cell Lung Carcinoma
Neurogenic locus notch homolog protein 2 inhibitor
TAREXTUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
333YMY788E
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ULILEDLIMAB
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
ULILEDLIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
XL-844
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Neoplasms
Serine/threonine-protein kinase Chk1 inhibitor
XL-844
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NEOSAXITOXIN
1
Small molecule
Investigational
Unknown
Unknown
Pain
Unknown
NEOSAXITOXIN
×
Maximum Phase:
1
First Approval:
None
UNII:
6YRL8BWD9H
Molecule Type:
Small molecule
Molecular Formula:
C10H17N7O5
Molecular Weight:
315.29
AlogP:
-3.54
PSA:
193.75
HBD:
7.0
HBA:
#RotB:
2.0
Source:
SNS-062
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SNS-062
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IRL-1620
1
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
IRL-1620
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-00562271
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Focal adhesion kinase 1 inhibitor
PF-00562271
×
Maximum Phase:
1
First Approval:
None
UNII:
K5BX8ZA7UF
Molecule Type:
Small molecule
Molecular Formula:
C21H20F3N7O3S
Molecular Weight:
507.5
AlogP:
3.14
PSA:
129.21
HBD:
3.0
HBA:
#RotB:
7.0
Source:
ANTI-PR1/HLA-A2 MONOCLONAL ANTIBODY HU8F4
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ANTI-PR1/HLA-A2 MONOCLONAL ANTIBODY HU8F4
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BPN-14967
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BPN-14967
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK-1795091
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
GSK-1795091
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ELINOGREL
1
Small molecule
Investigational
Unknown
Unknown
Kidney Diseases; Myocardial Infarction
Purinergic receptor P2Y12 antagonist
ELINOGREL
×
Maximum Phase:
1
First Approval:
None
UNII:
915Y8E749J
Molecule Type:
Small molecule
Molecular Formula:
C20H15ClFN5O5S2
Molecular Weight:
523.96
AlogP:
3.09
PSA:
142.16
HBD:
4.0
HBA:
#RotB:
5.0
Source:
PHI-101
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
PHI-101
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C19H19FN4O2S
Molecular Weight:
386.45
AlogP:
2.26
PSA:
96.25
HBD:
4.0
HBA:
#RotB:
3.0
Source:
TAK-960
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase PLK1 inhibitor
TAK-960
×
Maximum Phase:
1
First Approval:
None
UNII:
3831VFM1ZB
Molecule Type:
Small molecule
Molecular Formula:
C27H34F3N7O3
Molecular Weight:
561.61
AlogP:
3.55
PSA:
102.93
HBD:
2.0
HBA:
#RotB:
6.0
Source:
FN-1501
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
FN-1501
×
Maximum Phase:
1
First Approval:
None
UNII:
6MC966B505
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-936559
1
Unknown
Investigational
Unknown
Unknown
HIV Infections
Unknown
BMS-936559
×
Maximum Phase:
1
First Approval:
None
UNII:
TLZ6R6973Z
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AV-412
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AV-412
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PA-799
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
PI3-kinase class I inhibitor
PA-799
×
Maximum Phase:
1
First Approval:
None
UNII:
JCL936W835
Molecule Type:
Small molecule
Molecular Formula:
C15H19N7O3S
Molecular Weight:
377.43
AlogP:
-0.33
PSA:
127.43
HBD:
1.0
HBA:
#RotB:
3.0
Source:
DOTAMTATE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
DOTAMTATE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
C65H91N17O16PbS2
Molecular Weight:
1637.88
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
GLPG0259
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GLPG0259
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RGB-286638
1
Small molecule
Investigational
Unknown
Unknown
Hematologic Neoplasms
Cyclin-dependent kinase 1 inhibitor
RGB-286638
×
Maximum Phase:
1
First Approval:
None
UNII:
1GAJ98SC2X
Molecule Type:
Small molecule
Molecular Formula:
C29H35N7O4
Molecular Weight:
545.64
AlogP:
2.42
PSA:
115.06
HBD:
3.0
HBA:
#RotB:
8.0
Source:
BNT-162A1
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
BNT-162A1
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZADIRACHTA INDICA
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
AZADIRACHTA INDICA
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AST-487
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Tyrosine-protein kinase receptor FLT3 inhibitor
AST-487
×
Maximum Phase:
1
First Approval:
None
UNII:
W34UO2M4T6
Molecule Type:
Small molecule
Molecular Formula:
C26H30F3N7O2
Molecular Weight:
529.57
AlogP:
5.11
PSA:
94.65
HBD:
3.0
HBA:
#RotB:
8.0
Source:
IBI-188
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasms
Unknown
IBI-188
×
Maximum Phase:
1
First Approval:
None
UNII:
BDN84I1TFE
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LEXANERSEN
1
Oligonucleotide
Investigational
Unknown
Unknown
Huntington Disease
Unknown
LEXANERSEN
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Oligonucleotide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BIVATUZUMAB MERTANSINE
1
Antibody
Investigational
Unknown
Unknown
Unknown
CD44 antigen binding agent
BIVATUZUMAB MERTANSINE
×
Maximum Phase:
1
First Approval:
None
UNII:
074GT4PR9D
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OLAPTESED PEGOL
1
Unknown
Investigational
Unknown
Unknown
Glioblastoma; Pancreatic Neoplasms
Unknown
OLAPTESED PEGOL
×
Maximum Phase:
1
First Approval:
None
UNII:
MTM792B442
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD-6482
1
Small molecule
Investigational
Unknown
Unknown
Unknown
PI3-kinase class I inhibitor
AZD-6482
×
Maximum Phase:
1
First Approval:
None
UNII:
78G6MP5PZ5
Molecule Type:
Small molecule
Molecular Formula:
C22H24N4O4
Molecular Weight:
408.46
AlogP:
2.71
PSA:
96.17
HBD:
2.0
HBA:
#RotB:
5.0
Source:
GSK-625433
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GSK-625433
×
Maximum Phase:
1
First Approval:
None
UNII:
2YAD6KT0NT
Molecule Type:
Small molecule
Molecular Formula:
C26H32N4O5S
Molecular Weight:
512.63
AlogP:
4.02
PSA:
106.78
HBD:
1.0
HBA:
#RotB:
8.0
Source:
LIOTHYRONINE I 131
1
Small molecule
Investigational
Unknown
Unknown
Heart Defects, Congenital
Unknown
LIOTHYRONINE I 131
×
Maximum Phase:
1
First Approval:
None
UNII:
86AZ0G22V2
Molecule Type:
Small molecule
Molecular Formula:
C15H12I3NO4
Molecular Weight:
662.98
AlogP:
3.95
PSA:
92.78
HBD:
3.0
HBA:
#RotB:
5.0
Source:
CP-742,033
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CP-742,033
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IMAPRELIMAB
1
Antibody
Investigational
Unknown
Unknown
Psoriasis
Unknown
IMAPRELIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
IYH4W60MAZ
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LY2979165
1
Small molecule
Investigational
Unknown
Unknown
Bipolar Disorder
Metabotropic glutamate receptor 2 agonist
LY2979165
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DSTP3086S
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
DSTP3086S
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
111
112
113
114
115
116
117
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA